Posted by Michael Wonder on 06 Mar 2018
The Federal Right to Try Act of 2017—a wrong turn for access to investigational drugs and the path forward
6 March 2018 - In 2017, President Trump said that “one thing that’s always disturbed” him is that the US FDA denies access to experimental drugs even “for a patient who’s terminal…[who] is not going to live more than four weeks [anyway.]”
Fueled by emotionally charged anecdotes recirculated by libertarian political activists, 38 states have passed Right to Try laws. In 2017, the US Senate approved a bill that would create a national law.
As of December 2017, the US House of Representatives was considering the bill.
